Omron Q1 Operating Profit More Than Triples on AI-Driven Automation Orders; Guidance Raised

The Kyoto-based automation and healthcare group raised first-quarter revenue 26.1% to ¥209,864 million and operating profit 226.0% to ¥18,857 million — more than triple the prior year — as capital spending by semiconductor and secondary-battery makers ran ahead of plan. Net profit attributable to owners of the parent rose 131.1% to ¥10,635 million. Omron raised full-year guidance, lifting the operating profit forecast to ¥80,000 million from ¥62,000 million and the net profit forecast to ¥40,500 million from ¥27,500 million.

OMRON Corporation Q1 FY3/2027 earnings summary

Ahead of both last year and its own plan

OMRON Corporation (TSE: 6645) published consolidated first-quarter results for FY3/2027 on August 5, 2026, covering April 1 to June 30, 2026 under IFRS. Revenue rose 26.1% to ¥209,864 million and gross profit 28.8% to ¥97,500 million, widening the gross margin by one point to 46.5%. Operating profit climbed 226.0% to ¥18,857 million, profit before tax 217.8% to ¥18,483 million and net profit attributable to owners of the parent 131.1% to ¥10,635 million, for earnings per share of ¥54.08 against ¥23.37.

Management said both revenue and operating profit ran well ahead of the prior year and of its own start-of-year assumptions. Prior-year comparatives have been restated to exclude the Device & Module Solutions business, which was classified as a discontinued operation and is being carved out into a subsidiary.

Automation does the heavy lifting

Industrial Automation, which now supplies almost two-thirds of external revenue, grew 37.2% to ¥131,194 million and doubled segment profit to ¥21,252 million from ¥10,585 million. Omron attributed the gain to capturing semiconductor investment driven by AI demand and secondary-battery investment for data centres, alongside a broader customer base built through closer distributor relationships and a wider product line-up.

Healthcare grew revenue 16.7% to ¥36,432 million and roughly doubled segment profit to ¥2,401 million, helped by online sales promotions for blood-pressure monitors in Japan and Asia. Data Solutions lifted revenue 22.8% to ¥13,065 million and swung to a ¥253 million profit from a ¥51 million loss. Social Systems was the exception: revenue slipped 2.0% to ¥24,249 million and segment profit fell 62.5% to ¥64 million, as weak energy-storage system sales offset steady rail and management-service work.

Guidance raised across the board

On the strength of the quarter and an expectation that semiconductor and battery capex will stay above plan, Omron revised upward the full-year forecast it issued on May 13, 2026. Revenue guidance rose to ¥880,000 million from ¥820,000 million, operating profit to ¥80,000 million from ¥62,000 million, profit before tax to ¥79,000 million from ¥61,000 million, profit from continuing operations to ¥58,000 million from ¥45,000 million, and net profit attributable to owners of the parent to ¥40,500 million from ¥27,500 million. Against FY3/2026 actuals, the new numbers represent growth of 14.6% in revenue, 41.7% in operating profit and 82.1% in net profit.

Segment guidance was raised most for Industrial Automation, whose external revenue forecast went to ¥500,000 million from ¥440,000 million and operating profit to ¥65,000 million from ¥44,000 million. Healthcare was nudged up, Data Solutions left unchanged, and Social Systems trimmed — revenue to ¥148,000 million from ¥153,000 million and operating profit to ¥19,500 million from ¥22,500 million — on a tougher competitive environment in residential renewables. Assumed exchange rates from the second quarter onward were changed to ¥155 to the dollar, ¥180 to the euro and ¥23 to the yuan.

Total assets rose 1.5% to ¥1,384,140 million, held up by cash and equivalents accumulated against the capital restructuring of the discontinued business and a partial return of retirement benefit trust assets. Equity attributable to owners of the parent grew 1.2% to ¥832,083 million for a ratio of 60.1%. The company holds ¥217,900 million in cash and deposits plus a ¥70,000 million committed credit line. The annual dividend forecast is ¥110.00 per share against ¥104.00 for FY3/2026; the interim and year-end split has not yet been determined. Note that the ¥205.97 forecast earnings per share includes discontinued operations; on continuing operations alone the company calculates ¥294.97.

OMRON Corporation — Q1 FY3/2027 (April 1 – June 30, 2026), IFRS, consolidated. Balance-sheet rows compare June 30, 2026 with March 31, 2026; guidance and dividend rows are full-year FY3/2027 against FY3/2026. "—" indicates a figure not disclosed.
MetricQ1 FY3/2027Q1 FY3/2026Change
Revenue (¥ million)209,864166,480+26.1%
Gross profit (¥ million)97,50075,700+28.8%
Gross margin46.5%45.5%+1.0 pt
Operating profit (¥ million)18,8575,784+226.0%
Pre-tax profit (¥ million)18,4835,816+217.8%
Net profit (¥ million)10,9584,927+122.4%
Net profit attrib. to owners of parent (¥ million)10,6354,601+131.1%
Comprehensive income (¥ million)20,9926,048+247.1%
EPS (¥)54.0823.37+131.4%
Industrial Automation (IAB) — revenue (¥ million)131,19495,637+37.2%
Industrial Automation (IAB) — segment profit (¥ million)21,25210,585+100.8%
Healthcare (HCB) — revenue (¥ million)36,43231,222+16.7%
Healthcare (HCB) — segment profit (¥ million)2,4011,190+101.7%
Social Systems (SSB) — revenue (¥ million)24,24924,753-2.0%
Social Systems (SSB) — segment profit (¥ million)64171-62.5%
Data Solutions (DSB) — revenue (¥ million)13,06510,643+22.8%
Data Solutions (DSB) — segment profit (¥ million)253-51loss to profit
Total assets (¥ million)1,384,1401,363,359+1.5%
Equity attrib. to owners of parent (¥ million)832,083821,812+1.2%
Equity ratio60.1%60.3%-0.2 pt
FY3/2027 guidance — revenue (¥ million)880,000+14.6%
FY3/2027 guidance — operating profit (¥ million)80,000+41.7%
FY3/2027 guidance — pre-tax profit (¥ million)79,000+46.9%
FY3/2027 guidance — net profit (¥ million)40,500+82.1%
FY3/2027 guidance — EPS (¥)205.97
Annual dividend per share110.00104.00+5.8%

JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.